Nora Mokrani, Philippe Parola, Soraya Tebbal, Mokhtar Dalichaouche, Ahmed Aouati, and Didier Raoult
Author affiliations: Clinique des Maladies Infectieuses, Batna, Algeria (N. Mokrani, S. Tebbal); Unité des Rickettsies CNRS-IRD UMR, Marseille, France (P. Parola, D. Raoult); Service des Maladies Infectieuses, Constantine, Algeria (M. Dalichaouche, A. Aouati);
Figure. Western blot assay (WB) and cross-adsorption studies in serum of a patient with rickettsiosis in Algeria. Immunofluorescent assay showed raised levels of immunoglobulin (Ig) G/M at the same titer (2,048/32) against Rickettsia conorii, R. aeschlimannii, and R. massiliae. Lanes Rc, Rae, and Rm: WB assay using R. conorii, R. aeschlimannii, and R. massiliae antigens, respectively. MW, molecular weights are indicated on the left. Untreated serum, late serum samples tested by WB. When adsorption is performed with R. aeschlimannii antigens, homologous and heterologous antibodies disappear, but when it is performed with R. conorii antigens and R. massiliae, homologous antibodies disappear but heterologous antibodies persist. This result indicates that antibodies are specifically directed against R. aeschlimannii. Abs, absorbed.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.